Accuracy of the prostate health index versus the urinary prostate cancer antigen 3 score to predict overall and significant prostate cancer at initial biopsy-Reference-Cited by-同舟云学术

Accuracy of the prostate health index versus the urinary prostate cancer antigen 3 score to predict overall and significant prostate cancer at initial biopsy

Published:2014-10-18 Issue:1 Volume:75 Page:103-111
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Seisen Thomas¹²,Rouprêt Morgan¹²,Brault Didier²³,Léon Priscilla¹²,Cancel-Tassin Géraldine²⁴,Compérat Eva⁵,Renard-Penna Raphaële⁶,Mozer Pierre¹,Guechot Jérome³,Cussenot Olivier¹²⁴⁷

Affiliation:

1. Academic Department of Urology; Pitié-Salpétrière Hospital, AP-HP; Paris France

2. UPMC Univ Paris 06; GRC5; ONCOTYPE-URO; Institut Universitaire de Cancérologie; Paris France

3. Academic Department of Biochemistry; GH Paris Est, AP-HP; Paris France

4. CeRePP, Tenon Hospital; Paris France

5. Academic Department of Pathology; Pitié-Salpétrière Hospital, AP-HP; Paris France

6. Academic Department of Radiology; Pitié-Salpétrière Hospital, AP-HP; Paris France

7. Academic Department of Urology; GH Paris Est, AP-HP; Paris France

Funder

Access Hybritech p2PSA ([-2]proPSA) reagents were provided by Beckman Coulter Inc.

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.22898/fullpdf

Reference27 articles.

1. Radical prostatectomy versus watchful waiting in early prostate cancer;Bill-Axelson;N Engl J Med,2011

2. Prostate-cancer mortality at 11 years of follow-up;Schröder;N Engl J Med,2012

3. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality results after 13 years of follow-up;Andriole;J Natl Cancer Inst,2012

4. Screening for prostate cancer decreases the risk of developing metastatic disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC);Schröder;Eur Urol,2012

5. PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: A prospective multicenter clinical study;Gittelman;J Urol,2013

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of blood and urine based biomarkers for detection of clinically-significant prostate cancer;Prostate Cancer and Prostatic Diseases;2024-06-10

2. How to Integrate Prostate Cancer Biomarkers in Urology Clinical Practice: An Update;Cancers;2024-01-11

3. Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancer;Urologic Oncology: Seminars and Original Investigations;2023-11

4. Diagnostic Accuracy of Liquid Biomarkers for Clinically Significant Prostate Cancer Detection: A Systematic Review and Diagnostic Meta-analysis of Multiple Thresholds;European Urology Oncology;2023-11

5. Prostate health index (PHI) as an accurate prostate cancer predictor;Journal of Cancer Research and Clinical Oncology;2023-05-19